NPPC Gene (Natriuretic Peptide C)

Gene encoding C-type natriuretic peptide, a key regulator of skeletal growth and cardiovascular homeostasis

Gene Information Card

Symbol NPPC
Full Name Natriuretic Peptide C
Gene Type protein-coding
Chromosomal Location 2q37.1
NCBI Gene ID 4880 ncbi.nlm.nih.gov/gene/4880
Ensembl ID ENSG00000113161
UniProt ID P23582
OMIM ID 600296
HGNC ID 7940
Aliases CNP, C-type natriuretic peptide

Description

The NPPC gene encodes C-type natriuretic peptide (CNP), a member of the natriuretic peptide family. CNP is primarily expressed in the central nervous system, bone, and endothelium. It acts via the natriuretic peptide receptor B (NPR2) to stimulate cyclic GMP production, regulating skeletal growth, vascular tone, and reproductive function. Loss-of-function mutations cause acromesomelic dysplasia type Maroteaux, while gain-of-function mutations are associated with skeletal overgrowth.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Acromesomelic dysplasia, type Maroteaux (AMDM) Loss-of-function mutations in NPPC reduce CNP signaling via NPR2, impairing endochondral ossification and leading to short stature and skeletal abnormalities. OMIM #602875; PMID: 22549407
Skeletal overgrowth (Tall stature) Gain-of-function mutations (e.g., p.Arg117Gly) increase CNP activity, accelerating bone growth. PMID: 22549407; ClinVar
Cardiovascular disease CNP deficiency may contribute to hypertension and vascular remodeling due to reduced vasodilation and anti-proliferative effects. PMID: 15591044

Expression Profile

Tissue Expression
Tissue nTPM level
Bone 0.8 Low
Brain 4.2 Medium
Heart 1.5 Low
Kidney 0.6 Low
Lung 2.1 Low
Vascular endothelium 3.0 Medium
Cell Line Expression
Cell Line nTPM Notes
HUVEC (endothelial) 3.5 Primary endothelial cells
SH-SY5Y (neuroblastoma) 2.8 Neuronal lineage
MG-63 (osteosarcoma) 1.2 Bone-derived
HEK293 0.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.349C>T (p.Arg117Gly) Missense Rare Gain-of-function; increased CNP activity, tall stature
c.1A>G (p.Met1?) Start loss Very rare Loss-of-function; acromesomelic dysplasia
c.226C>T (p.Arg76*) Nonsense Rare Loss-of-function; premature truncation, AMDM
Mutation functional classification

Loss of Function (LOF)

Nonsense, frameshift, and start-loss mutations that reduce or abolish CNP production, leading to acromesomelic dysplasia type Maroteaux.

Gain of Function (GOF)

Missense mutations (e.g., p.Arg117Gly) that enhance CNP receptor binding or stability, causing skeletal overgrowth.

Dominant Negative (DN)

Not reported for NPPC.

Pathways

Natriuretic peptide signaling pathway (Reactome: R-HSA-418594)
cGMP-PKG signaling pathway (KEGG: hsa04022)
Skeletal development and growth plate regulation

Protein Summary

C-type natriuretic peptide (CNP) is a 22-amino acid mature peptide (after proteolytic processing) that binds to natriuretic peptide receptor B (NPR2). It is synthesized as a preproprotein of 126 residues. CNP lacks the C-terminal tail typical of ANP and BNP. It plays a critical role in endochondral bone growth by stimulating cGMP production in chondrocytes. CNP also acts as a paracrine vasodilator and inhibits vascular smooth muscle proliferation.

Related Products

Product name Cat.No. Species Gene ID
NPPC Knockout HEK293 Cell Line EDJ-KQ1839 Human 4880 Details Get a Quote
NPPC Knockout HeLa Cell Line EDJ-KQ54016 Human 4880 Details Get a Quote
NPPC Knockout A-549 Cell Line EDJ-KQ62506 Human 4880 Details Get a Quote
NPPC Knockout HCT 116 Cell Line EDJ-KQ70975 Human 4880 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: